Loading...
MetLife, Inc.
MET-PE•NYSE
Financial ServicesInsurance - Life
$23.62
$-0.04(-0.17%)
MetLife, Inc. (MET-PE) Financial Performance & Statements
Review MetLife, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
5.26%
↑ 5.26%
Operating Income Growth
208.002%
↑ 208.002%
Net Income Growth
180.48%
↑ 180.48%
Operating Cash Flow Growth
6.39%
↑ 6.39%
Operating Margin
8.84%
↑ 8.84%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
6.18%
↑ 6.18%
ROE
15.93%
↑ 15.93%
ROIC
0.94%
↑ 0.94%
MetLife, Inc. (MET-PE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for MetLife, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $18.38B | $18.44B | $17.82B | $16.06B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $18.38B | $18.44B | $17.82B | $16.06B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.51B | $1.49B | $1.48B | $1.51B |
| Operating Expenses | $17.00B | $16.26B | $16.28B | $14.86B |
| Total Costs & Expenses | $17.00B | $16.26B | $16.28B | $14.86B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $259.00M | $257.00M | $257.00M | $264.00M |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | -$1.31B |
| EBITDA | $1.64B | $0.00 | $0.00 | $0.00 |
| EBITDA Ratio | $0.09 | $0.00 | $0.00 | $0.00 |
| Operating Income | $1.38B | $2.25B | $1.46B | $1.04B |
| Operating Income Ratio | $0.08 | $0.12 | $0.08 | $0.07 |
| Other Income/Expenses (Net) | $0.00 | -$257.00M | -$257.00M | $0.00 |
| Income Before Tax | $1.38B | $1.99B | $1.20B | $1.04B |
| Income Before Tax Ratio | $0.08 | $0.11 | $0.07 | $0.07 |
| Income Tax Expense | $106.00M | $653.00M | $249.00M | $170.00M |
| Net Income | $1.27B | $1.34B | $946.00M | $867.00M |
| Net Income Ratio | $0.07 | $0.07 | $0.05 | $0.05 |
| EPS | $1.78 | $1.82 | $1.28 | $1.11 |
| Diluted EPS | $1.78 | $1.81 | $1.28 | $1.10 |
| Weighted Avg Shares Outstanding | $696.07M | $699.30M | $710.50M | $723.20M |
| Weighted Avg Shares Outstanding (Diluted) | $697.90M | $703.70M | $714.70M | $728.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan